Cancer is the second leading cause of death globally, but conventional anticancer drugs have side effects, mainly due to their non-specific distribution in the body in both cancerous and healthy cells. To address this relevant issue and improve the efficiency of anticancer drugs, increasing attention is being devoted to hydrogel drug-delivery systems for different kinds of cancer treatment due to their high biocompatibility and stability, low side effects, and ease of modifications. To improve the therapeutic efficiency and provide multi-functionality, different types of nanoparticles (NPs) can be incorporated within the hydrogels to form smart hydrogel nanocomposites, benefiting the advantages of both counterparts and suitable for advanced anticancer applications. Despite many papers on non-peptide hydrogel nanocomposites, there is limited knowledge about peptide-based nanocomposites, specifically in anti-cancer drug delivery. The aim of this short but comprehensive review is, therefore, to focus attention on the synergies resulting from the combination of NPs with peptide-based hydrogels. This review, which includes a survey of recent advances in this kind of material, does not aim to be an exhaustive review of hydrogel technology, but it instead highlights recent noteworthy publications and discusses novel perspectives to provide valuable insights into the promising synergic combination of peptide hydrogels and NPs for the design of novel anticancer drug delivery systems.

Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery / HAJAREH HAGHIGHI, Farid; Binaymotlagh, Roya; Fratoddi, Ilaria; Chronopoulou, Laura; Palocci, Cleofe. - In: GELS. - ISSN 2310-2861. - 9:12(2023), pp. 1-23. [10.3390/gels9120953]

Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery

Farid Hajareh Haghighi;Roya Binaymotlagh;Ilaria Fratoddi;Laura Chronopoulou;Cleofe Palocci
2023

Abstract

Cancer is the second leading cause of death globally, but conventional anticancer drugs have side effects, mainly due to their non-specific distribution in the body in both cancerous and healthy cells. To address this relevant issue and improve the efficiency of anticancer drugs, increasing attention is being devoted to hydrogel drug-delivery systems for different kinds of cancer treatment due to their high biocompatibility and stability, low side effects, and ease of modifications. To improve the therapeutic efficiency and provide multi-functionality, different types of nanoparticles (NPs) can be incorporated within the hydrogels to form smart hydrogel nanocomposites, benefiting the advantages of both counterparts and suitable for advanced anticancer applications. Despite many papers on non-peptide hydrogel nanocomposites, there is limited knowledge about peptide-based nanocomposites, specifically in anti-cancer drug delivery. The aim of this short but comprehensive review is, therefore, to focus attention on the synergies resulting from the combination of NPs with peptide-based hydrogels. This review, which includes a survey of recent advances in this kind of material, does not aim to be an exhaustive review of hydrogel technology, but it instead highlights recent noteworthy publications and discusses novel perspectives to provide valuable insights into the promising synergic combination of peptide hydrogels and NPs for the design of novel anticancer drug delivery systems.
2023
peptide; peptide-based hydrogels; nanoparticles; nanocomposite; cancer; drug delivery
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery / HAJAREH HAGHIGHI, Farid; Binaymotlagh, Roya; Fratoddi, Ilaria; Chronopoulou, Laura; Palocci, Cleofe. - In: GELS. - ISSN 2310-2861. - 9:12(2023), pp. 1-23. [10.3390/gels9120953]
File allegati a questo prodotto
File Dimensione Formato  
Haghighi_Peptide-Hydrogel_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.51 MB
Formato Adobe PDF
2.51 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1693240
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact